Pain relief provided by a caudal epidural following robotic surgery removing the prostate while under general anaesthesia

ISRCTN ISRCTN86549389
DOI https://doi.org/10.1186/ISRCTN86549389
Secondary identifying numbers CA 3049
Submission date
28/04/2025
Registration date
29/04/2025
Last edited
29/04/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
This study is looking at how effective a pain-relieving injection, called a caudal block, is for patients having robotic-assisted surgery to remove the prostate gland. The aim is to see if this injection can help reduce pain after the surgery and lessen the need for stronger painkillers like morphine.

Who can participate?
Patients who are scheduled to have robotic-assisted prostate surgery at Galway University Hospital can participate in this study.

What does the study involve?
Participants will be randomly divided into two groups. One group will receive the standard pain relief methods, while the other group will receive an additional caudal block injection. This injection is given while the patient is under general anaesthetic and helps numb the lower half of the body.

What are the possible benefits and risks of participating?
The possible benefits include better pain relief after surgery and a quicker recovery. The risks are minimal but may include side effects from the caudal block, such as temporary numbness or discomfort.

Where is the study run from?
Galway University Hospital (Ireland)

When is the study starting and how long is it expected to run for?
June 2023 to December 2023.

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Dr Eoin Coughlan, eoin645@outlook.com
Patrick O'Malley, paddyomalley@hotmail.com
Dr Patrick Neligan, pjneligan@yahoo.com

Contact information

Dr Eoin Coughlan
Public, Scientific

Apt 31, Merton Hall
Milltown Avenue, Mount St Annes
Dublin 6
D06 DX00
Ireland

ORCiD logoORCID ID 0009-0007-3482-0698
Phone +353 851646017
Email eoin645@outlook.com
Mr Patrick O'Malley
Principal Investigator

Galway University Hospital
Galway
H91 YR71
Ireland

Phone +353 874194709
Email paddyomalley@hotmail.com
Dr Patrick Neligan
Principal Investigator

Galway University Hospital
Galway
H91 YR71
Ireland

Phone +353 879687096
Email pjneligan@yahoo.com

Study information

Study designRandomised single-blinded controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeQuality of life, Treatment, Efficacy
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleAnalgesic requirements following caudal epidural in elective robotic prostatectomy
Study objectivesCaudal epidural decreases post-operative opioid analgesic requirements in robotic prostatectomy as opposed to protocolled multimodal analgesia alone
Ethics approval(s)

Approved 06/07/2023, Galway University Hospital Ethics Committee (Newcastle Road, Galway, H91 YR71, Ireland; +353 91524222; consumeraffairs.west@hse.ie), ref: CA 3049

Health condition(s) or problem(s) studiedRobotic prostatectomy
InterventionGeneral anaesthesia for the procedure will be standardised and include the administration of abdominal wall blocks and morphine. The study intervention is to administer an additional caudal epidural block to patients randomised into the intervention group. The patients who are administered standard anaesthesia will henceforth be called the ‘control’ group.

Candidates will be randomised into 2 groups. This will be done by the last digit of the patient’s board number. The candidates with an even final digit of their board number will be considered for caudal block. The candidates with an odd final digit will not be given a caudal block.
Intervention typeProcedure/Surgery
Primary outcome measure1. Cumulative opioid consumption in the 24 hour post-operative period measured using patient records
Secondary outcome measures1. Pain (visual analogue) score at 2, 4, 6, and 24 hours post-procedure
2. Cumulative requirements for anti-emetic therapy in the first 24 hours post-operatively
3. Richmond Agitation-Sedation Score at 2, 4, 6, and 24 hours post-procedure
Overall study start date01/06/2023
Completion date31/12/2023

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit25 Years
Upper age limit90 Years
SexMale
Target number of participants75
Total final enrolment70
Key inclusion criteriaThose undergoing elective radical robotic prostatectomy
Key exclusion criteria1. Participant refusal
2. Treatment for chronic pain
3. Psychiatric illness
4. Local pathology of the spine
Date of first enrolment12/06/2023
Date of final enrolment13/12/2023

Locations

Countries of recruitment

  • Ireland

Study participating centre

Galway University Hospital
Newcastle Road
Galway
H91 YR71
Ireland

Sponsor information

Ollscoil na Gaillimhe – University of Galway
University/education

Newcastle Road
Galway
H91 YR71
Ireland

Phone +353 91524222
Email consumeraffairs.west@hse.ie
Website https://www.universityofgalway.ie
ROR logo "ROR" https://ror.org/03bea9k73

Funders

Funder type

Other

Investigator initiated and funded

No information available

Results and Publications

Intention to publish date01/06/2025
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a peer-reviewed journal
IPD sharing planThe datasets generated during and / or analysed during the current study will be available upon request from Eoin Coughlan - eoin645@outlook.com

Editorial Notes

29/04/2025: Trial's existence confirmed by Galway University Hospital Ethics Committee.